Symbol
| PDCD5
| contributors: mct/npt - updated : 10-04-2019
|
HGNC name
| programmed cell death 5
|
HGNC id
| 8764
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
| --over
|  
|
and nuclear translocation of PDCD5 in rheumatoid arthritis patient-derived fibroblast-like synoviocytes undergoing apoptosis (Wang 2007) | tumoral
|  
|  
| --low
|  
|
associated with high-grade astrocytic gliomas (Li 2008) | tumoral
|  
|  
| --low
|  
|
in the high malignant group of glioma significantly decreased compared with the low malignant group | tumoral
|  
|  
| --low
|  
|
may contribute to the pathogenesis of human ovarian serous cystadenocarcinomas | |
Susceptibility
|
to lung cancer risk and prognosis |
Variant & Polymorphism
other
| rs1862214 polymorphism in PDCD5 is predictive for lung cancer risk and prognosis (Spinola 2006) |
|
|
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
cancer | brain | glioma/neuroblstoma | |
PDCD5 mRNA expressions is promising target for the diagnosis and treatment of glioma |
| | | |
| Pdcd5 knockout in mouse embryos results in placental defects and embryonic lethality |